Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under Immunotherapy

SIMPLE SUMMARY: Splenic volume (SV) has been identified as a highly predictive parameter for prognosis in patients with hepatocellular carcinoma (HCC). Moreover, an association between immunotherapy and an increase in SV has been described for various types of cancer. In our cohort of patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Lukas, Gairing, Simon Johannes, Kloeckner, Roman, Foerster, Friedrich, Weinmann, Arndt, Mittler, Jens, Stoehr, Fabian, Emrich, Tilman, Düber, Christoph, Galle, Peter Robert, Hahn, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332404/
https://www.ncbi.nlm.nih.gov/pubmed/35892833
http://dx.doi.org/10.3390/cancers14153574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332404/
https://www.ncbi.nlm.nih.gov/pubmed/35892833
http://dx.doi.org/10.3390/cancers14153574

Ejemplares similares